Gitlab Inc. (GTLB) stock: key figures, P/E, revenue and dividend
Information Technology · United States · ISIN US37637K1088
Gitlab Inc. financials
| Fiscal year | 2025 | 2026 |
|---|---|---|
| Revenue | 759.25 m USD | 955.22 m USD |
| Gross profit | 674.11 m USD | 834.48 m USD |
| Operating income | -142.72 m USD | -70.48 m USD |
| EBIT | -133.53 m USD | -93.77 m USD |
| Net income | -6.33 m USD | -55.96 m USD |
| Diluted EPS – continuing operations | -0.04 USD | -0.34 USD |
Full history since 2019, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Gitlab Inc.
GitLab Inc., together with its subsidiaries, develops software for the software development lifecycle in the United States, Europe, and the Asia Pacific. The company provides GitLab, an intelligent orchestration platform for DevSecOps, which is a single application offering the entire software development lifecycle, including software, project plans, code, security scans, compliance checks, and deployment configurations. It also offers the GitLab Duo Agent Platform, which enables intelligent orchestration of teams and AI agents to execute tasks autonomously across planning, development, security, and deployment. This platform combines conversational AI assistance, purpose-built agents for specialized tasks, workflow automation, and enterprise controls. In addition, it offers related training and professional services. The company was formerly known as GitLab B.V. and changed its name to GitLab Inc. in July 2015. GitLab Inc. was founded in 2011 and is based in San Francisco, California.
More stocks
- Sichuan Kelun Pharmaceutical Co Ltd (002422.SZ)
- Life Time Group Holdings, Inc. (LTH)
- Ackermans & Van Haaren NV (ACKB.BR)
- Ivanhoe Mines Ltd (IVN.TO)
- ADVANCED ENERGY INDUSTRIES INC (AEIS)
- Eneva S.A (ENEV3.SA)
- Match Group, Inc. (MTCH)
- Krystal Biotech, Inc. (KRYS)
- ZIONS BANCORPORATION, NATIONAL ASSOCIATION /UT/ (ZION)
- Poly Real Estate Group Co Ltd (600048.SS)
- Xizang Haisco Pharmaceutical Group Co Ltd (002653.SZ)
- Allwyn AG (ALWN.AT)
Not investment advice. All data without warranty, price as of 22.10.2026. Details in the risk notice.